The Burden of image based emphysema and bronchiolitis in HIV-infected individuals on antiretroviral therapy

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Guaraldi, Giovanni ^a   Besutti, Giulia ^a   Scaglioni, Riccardo ^a   Santoro, Antonella ^a   Zona, Stefano ^a   Guido, Ligabue ^a   Marchioni, Alessandro ^a   Orlando, Gabriella ^a   Carli, Federica ^a   Beghe, Bianca ^a   Fabbri, Leonardo ^a   Leipsic, Jonathon ^b   Sin, Don D ^b,c   Man, S F Paul ^b,c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CARBON MONOXIDE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACUTE DISEASE; ADULT; ANAMNESIS; ANTHROPOMETRY; ARTICLE; BRONCHIOLITIS; COMPUTED TOMOGRAPHY SCANNER; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LEUKOCYTOSIS; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHENOTYPE; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SMOKING; STATISTICAL PARAMETERS; TERTIARY HEALTH CARE; THORAX RADIOGRAPHY; AREA UNDER THE CURVE; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; HIV INFECTIONS; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PULMONARY EMPHYSEMA; RADIOGRAPHY;

ADULT; ANTI-RETROVIRAL AGENTS; AREA UNDER CURVE; BRONCHIOLITIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84908546430     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109027     Document Type: Article

References (27)

1. Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, et al. (2008) Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 300: 51-59.
2. Palella FJ, Jr., Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860.
3. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, et al. (2007) Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 146: 87-95.
4. Palella FJ, Jr., Baker RK, Moorman AC, Chmiel JS, Wood KC, et al. (2006) Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 43: 27-34.
5. Antiretroviral Therapy Cohort C (2010) Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 50: 1387-1396.
6. Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, et al. (2008) Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 118: e29-35.
7. Guiguet M, Boue F, Cadranel J, Lang JM, Rosenthal E, et al. (2009) Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 10: 1152-1159.
8. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV (2006) Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 145: 397-406.
9. Grinspoon S, Carr A (2005) Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352: 48-62.
10. Gingo MR, George MP, Kessinger CJ, Lucht L, Rissler B, et al. (2010) Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 182: 790-796.
11. Madeddu G, Fois AG, Calia GM, Babudieri S, Soddu V, et al. (2012) Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection.
12. Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, et al. (2000) Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 132: 369-372.
13. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, et al. (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246: 697-722.
14. Kuk JL, Church TS, Blair SN, Ross R (2006) Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome? Diabetes Care 29: 679-684.
15. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, et al. (2005) General considerations for lung function testing. Eur Respir J 26: 153-161.
16. Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, et al. (1997) Thinsection CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 169: 977-983.
17. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, et al. (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26: 511-522.
18. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, et al. (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26: 720-735.
19. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, et al. (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16: 5-40.
20. Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC (1993) Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16: 41-52.
21. Stocks J, Quanjer PH (1995) Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. Eur Respir J 8: 492-506.
22. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, et al. (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53: 1120-1126.
23. Bestilny LJ, Gill MJ, Mody CH, Riabowol KT (2000) Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS 14: 771-780.
24. Wolthers KC, Bea G, Wisman A, Otto SA, de Roda Husman AM, et al. (1996) T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 274: 1543-1547.
25. Alder JK, Guo N, Kembou F, Parry EM, Anderson CJ, et al. (2011) Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med 184: 904-912.
26. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, et al. (2011) Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365: 1567-1575.
27. Barr RG, Ahmed FS, Carr JJ, Hoffman EA, Jiang R, et al. (2012) Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Eur Respir J 39: 846-854.